The FDA gave Class I status to the massive recall of Symbios pain management products, meaing the federal watchdog agency believes the devices could cause serious injury or death.
Symbios last month warned that components of its pain management kits made before July 2012 could deliver dangerously high drug-release flow rates, meaning patients could be poisoned by rapid medication influx.